Mouth ulcers or aphthous ulcers are painful open sores or lesions that are mostly found inside the mouth, either singly or in clusters. Mouth ulcers are extremely common and most prevalence among the global population. Mouth ulcers treatment can range from simply smoothing or removing a local cause of trauma, to addressing underlying factors such as dry mouth or substituting a problem medication. Maintaining good oral hygiene and use of an antiseptic mouthwash or spray (e.g. chlorhexidine) can prevent secondary infection and therefore hasten healing. A topical analgesic (e.g. benzydamine mouthwash) may reduce pain. Topical (gels, creams or inhalers) or systemic steroids may be used to reduce inflammation. An antifungal drug may be used to prevent oral candidiasis developing in those who use prolonged steroids. Various classes of drugs such as corticosteroid, analgesic, anesthetic, antihistamine and antimicrobial are utilized for the treatment of mouth ulcers.
The global mouth ulcers drugs market report estimates the market size (Revenue USD million – 2014 to 2021) for key market segments based on the indications (aphthous stomatitis, oral lichen planus, etc.), drug classes (analgesic, anesthetic, antihistamine, antimicrobial, and Corticosteroids), formulation type (gel, lozenge, mouthwash, and sprays), and forecasts growth trends (CAGR% – 2017 to 2021).
The global mouth ulcers drugs market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global mouth ulcers drugs market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global mouth ulcers drugs market and included in this report are 3M Healthcare, Bristol Meyer Squibb Company, ECR Pharmaceuticals, GlaxoSmithKline plc and Church & Dwight Co, Inc. and others.